Magenta Therapeutics Inc
MGTA
Get informed when a big investor buys or sells
+ FollowMarket Cap$42.44M
Close$
Share Statistics
| Market cap | $42.44 Million |
|---|---|
| Enterprise Value | $-582,376,976.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 2.11 |
| Outstanding Shares | 0 |
Return
| Return on Equity | -14.46% |
|---|---|
| Return on Assets | -13.93% |
| Return on Invested Capital | -15.83% |
Valuation & Multiples
| P/E Ratio | -0.02 |
|---|---|
| PEG | -0.05 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -667.1 |
| Enterprise Value to EBIT | 3.04 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Magenta Therapeutics Inc
CEO: Jason Gardner